239 related articles for article (PubMed ID: 25980435)
1. YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment.
Gopal SK; Greening DW; Mathias RA; Ji H; Rai A; Chen M; Zhu HJ; Simpson RJ
Oncotarget; 2015 May; 6(15):13718-30. PubMed ID: 25980435
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells.
Gopal SK; Greening DW; Hanssen EG; Zhu HJ; Simpson RJ; Mathias RA
Oncotarget; 2016 Apr; 7(15):19709-22. PubMed ID: 26919098
[TBL] [Abstract][Full Text] [Related]
3. Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis.
Gopal SK; Greening DW; Zhu HJ; Simpson RJ; Mathias RA
Sci Rep; 2016 Jun; 6():28321. PubMed ID: 27324842
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.
Tauro BJ; Mathias RA; Greening DW; Gopal SK; Ji H; Kapp EA; Coleman BM; Hill AF; Kusebauch U; Hallows JL; Shteynberg D; Moritz RL; Zhu HJ; Simpson RJ
Mol Cell Proteomics; 2013 Aug; 12(8):2148-59. PubMed ID: 23645497
[TBL] [Abstract][Full Text] [Related]
5. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.
Liang C; Ma Y; Yong L; Yang C; Wang P; Liu X; Zhu B; Zhou H; Liu X; Liu Z
Cancer Sci; 2019 Jan; 110(1):166-179. PubMed ID: 30426615
[TBL] [Abstract][Full Text] [Related]
6. Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells.
Oyanadel C; Holmes C; Pardo E; Retamal C; Shaughnessy R; Smith P; Cortés P; Bravo-Zehnder M; Metz C; Feuerhake T; Romero D; Roa JC; Montecinos V; Soza A; González A
Mol Biol Cell; 2018 Mar; 29(5):557-574. PubMed ID: 29298841
[TBL] [Abstract][Full Text] [Related]
7. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.
Kobayashi W; Ozawa M
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):133-8. PubMed ID: 24269234
[TBL] [Abstract][Full Text] [Related]
9. Reduced adhesive ligand density in engineered extracellular matrices induces an epithelial-mesenchymal-like transition.
Marlar S; Abdellatef SA; Nakanishi J
Acta Biomater; 2016 Jul; 39():106-113. PubMed ID: 27163400
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase-2, RNA-binding proteins and mitochondrial proteins selectively traffic to MDCK cell-derived microvesicles following H-Ras-induced epithelial-mesenchymal transition.
Shafiq A; Suwakulsiri W; Rai A; Chen M; Greening DW; Zhu HJ; Xu R; Simpson RJ
Proteomics; 2021 Jul; 21(13-14):e2000221. PubMed ID: 33638284
[TBL] [Abstract][Full Text] [Related]
11. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition.
Izawa G; Kobayashi W; Haraguchi M; Sudo A; Ozawa M
Int J Mol Med; 2015 Jul; 36(1):166-72. PubMed ID: 25998899
[TBL] [Abstract][Full Text] [Related]
12. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
14. YB-1 overexpression promotes a TGF-β1-induced epithelial-mesenchymal transition via Akt activation.
Ha B; Lee EB; Cui J; Kim Y; Jang HH
Biochem Biophys Res Commun; 2015 Mar; 458(2):347-51. PubMed ID: 25645014
[TBL] [Abstract][Full Text] [Related]
15. YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.
Kosnopfel C; Sinnberg T; Sauer B; Busch C; Niessner H; Schmitt A; Forchhammer S; Grimmel C; Mertens PR; Hailfinger S; Dunn SE; Garbe C; Schittek B
Mol Cancer Res; 2018 Jul; 16(7):1149-1160. PubMed ID: 29743296
[TBL] [Abstract][Full Text] [Related]
16. P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition.
Zhang Y; Young A; Zhang J; Chen X
Oncotarget; 2015 Jun; 6(16):13994-4004. PubMed ID: 26101856
[TBL] [Abstract][Full Text] [Related]
17. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.
Moreno-Bueno G; Cubillo E; Sarrió D; Peinado H; Rodríguez-Pinilla SM; Villa S; Bolós V; Jordá M; Fabra A; Portillo F; Palacios J; Cano A
Cancer Res; 2006 Oct; 66(19):9543-56. PubMed ID: 17018611
[TBL] [Abstract][Full Text] [Related]
18. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
19. Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration.
Mathias RA; Chen YS; Wang B; Ji H; Kapp EA; Moritz RL; Zhu HJ; Simpson RJ
J Proteome Res; 2010 Feb; 9(2):1007-19. PubMed ID: 19954229
[TBL] [Abstract][Full Text] [Related]
20. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
